共 50 条
- [31] Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma Leukemia, 2018, 32 : 565 - 569
- [36] Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with Romidepsin CASE REPORTS IN ONCOLOGY, 2020, 13 (03): : 1402 - 1409